ITK/TRKA-IN-1 is a selective inhibitor targeting IL-2-inducible T-cell kinase (ITK) and tropomyosin receptor kinase A (TRKA), exhibiting an IC50 of 1.0 nM for ITK and achieving 96% inhibition of TRKA. This compound is valuable for investigating the roles of ITK and TRKA in immune responses and neurobiology. Its dual inhibitory action positions it as a significant tool for research in cancer immunotherapy and neurodegenerative disease studies, enabling the exploration of signaling pathways associated with these kinases.
ITK/TRKA-IN-1 is a selective inhibitor targeting IL-2-inducible T-cell kinase (ITK) and tropomyosin receptor kinase A (TRKA), exhibiting an IC50 of 1.0 nM for ITK and achieving 96% inhibition of TRKA. This compound is valuable for investigating the roles of ITK and TRKA in immune responses and neurobiology. Its dual inhibitory action positions it as a significant tool for research in cancer immunotherapy and neurodegenerative disease studies, enabling the exploration of signaling pathways associated with these kinases.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
